Finland· FI-REL-REL16765
Bonoq Uro
A gatifloxacin product containing gatifloxacin sesquihydrate, registered in Finland by Grünenthal GmbH. The same ATC class is registered in 2 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Gatifloxacin is registered in 2 of 19 countries.
Countries holding a registration under ATC J01MA16 (gatifloxacin), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 1 of them publish a price we can compare per daily dose
Gatifloxacin · ATC J01MA16
2 / 19 countries
- Finlandprice
- Japan
The record
At a glance
Fimea (Finland)- Active substance
- Gatifloxacin sesquihydrate
- Manufacturer
- Grünenthal GmbH
- Country
- Finland (FI)
- ATC code
- J01MA16
- ATC class
- Gatifloxacin
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
422 interactions on record for gatifloxacin.
Graded by severity as the source publishes them — 202 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Gatifloxacin · interactions on record
422 records
- 202 severe
- 94 moderate
- 51 minor
- 74 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Gatifloxacin in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f71dbf93-5898-4401-a287-1967e66419e8 GET /v1/drugs/f71dbf93-5898-4401-a287-1967e66419e8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.4",
"form": "tabletti, kalvopäällysteinen",
"route": null,
"ddd_unit": "g",
"strength": "400 mg",
"atc_label": "gatifloksasiini",
"ma_number": "17091",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL16765",
"authorised_at": "2002-10-21"
}See everything about gatifloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.